Tower Research Capital LLC (Trc) Care Dx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Care Dx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,922 shares of CDNA stock, worth $96,089. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,922
Previous 600
553.67%
Holding current value
$96,089
Previous $18,000
361.11%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CDNA
# of Institutions
223Shares Held
54.5MCall Options Held
59.3KPut Options Held
28K-
Black Rock Inc. New York, NY5.29MShares$130 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$119 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$65.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$59 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$54.1 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.31B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...